Department of Cardiac Surgery and Transplantology, Collegium Medicum, Jagiellonian University, John Paul II Hospital Cracow, Poland.
Med Sci Monit. 2010 Sep;16(9):CR440-4.
Because creatinine is an unreliable variable describing kidney function, the search for a new and sensitive marker of kidney function is underway. Neutrophil gelatinase-associated lipocalin (NGAL) has been recently proven useful in the quantitation of chronic kidney disease (CKD). The aim of the study was to assess the prevalence of chronic kidney disease using estimated glomerular filtration rate (eGFR) and creatinine clearance according to different formulas and measurements of cystatin C and serum NGAL.
MATERIAL/METHODS: One hundred sixty-nine prevalent heart transplant recipients in relation to age (younger and older than 65 years of age) were studied. Serum NGAL, cystatin C, creatinine, and eGFR were evaluated in all patients.
Elderly heart recipients had significantly higher cystatin C and serum NGAL and lower eGFR than their younger counterparts, despite not having a statistically different serum creatinine. In the group of 27 elderly recipients, according to the Cockcroft-Gault formula, 22 patients had stage 3 CKD and 4 had stage 4 CKD; according to the Modification of Diet in Renal Disease (MDRD) Study formula, 5 had stage 2 CKD, 15 had stage 3 CKD, and 7 had stage 4 CKD; according to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula, 5 had stage 2 CKD, 15 had stage 3 CKD, and 7 had stage 4 CKD; and according to the calculation of 24-hour creatinine clearance, 5 had stage 2 CKD, 16 had stage 3 CKD, and 6 had stage 4 CKD.
The prevalence of CKD in the elderly population was as high as 81% (MDRD, CKD-EPI, creatinine clearance) to 100% (Cockcroft-Gault formula), whereas in the younger population of heart transplant recipients the prevalence of CKD ranged from 56.3% to 77.5%. Serum NGAL could be a sensitive marker of kidney function, particularly in elderly patients.
由于肌酐是描述肾功能的不可靠变量,因此正在寻找新的、敏感的肾功能标志物。中性粒细胞明胶酶相关脂质运载蛋白(NGAL)已被证明在定量慢性肾脏病(CKD)方面非常有用。本研究的目的是评估使用估算肾小球滤过率(eGFR)和根据不同公式和胱抑素 C 和血清 NGAL 测量值计算的肌酐清除率来评估慢性肾脏病的患病率。
材料/方法:研究了 169 例与年龄相关(年龄小于 65 岁和大于 65 岁)的现患心脏移植受者。所有患者均评估了血清 NGAL、胱抑素 C、肌酐和 eGFR。
老年心脏受者的胱抑素 C 和血清 NGAL 明显高于年轻受者,eGFR 明显低于年轻受者,尽管血清肌酐无统计学差异。在 27 名老年受者中,根据 Cockcroft-Gault 公式,22 名患者患有 3 期 CKD,4 名患者患有 4 期 CKD;根据 MDRD 研究公式,5 名患者患有 2 期 CKD,15 名患者患有 3 期 CKD,7 名患者患有 4 期 CKD;根据 CKD-EPI 公式,5 名患者患有 2 期 CKD,15 名患者患有 3 期 CKD,7 名患者患有 4 期 CKD;根据 24 小时肌酐清除率计算,5 名患者患有 2 期 CKD,16 名患者患有 3 期 CKD,6 名患者患有 4 期 CKD。
老年人群中 CKD 的患病率高达 81%(MDRD、CKD-EPI、肌酐清除率)至 100%(Cockcroft-Gault 公式),而年轻心脏移植受者的 CKD 患病率范围为 56.3%至 77.5%。血清 NGAL 可能是肾功能的敏感标志物,特别是在老年患者中。